1. Home
  2. PRAX vs EXP Comparison

PRAX vs EXP Comparison

Compare PRAX & EXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$364.58

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Logo Eagle Materials Inc

EXP

Eagle Materials Inc

HOLD

Current Price

$202.92

Market Cap

7.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
EXP
Founded
2015
1963
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building Materials
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
7.0B
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
PRAX
EXP
Price
$364.58
$202.92
Analyst Decision
Strong Buy
Hold
Analyst Count
15
9
Target Price
$572.13
$227.11
AVG Volume (30 Days)
401.0K
435.8K
Earning Date
05-08-2026
05-19-2026
Dividend Yield
N/A
0.49%
EPS Growth
N/A
N/A
EPS
N/A
3.29
Revenue
N/A
$495,023,000.00
Revenue This Year
N/A
$1.97
Revenue Next Year
$7,758.26
$1.95
P/E Ratio
N/A
$62.73
Revenue Growth
N/A
N/A
52 Week Low
$37.25
$171.99
52 Week High
$392.45
$245.53

Technical Indicators

Market Signals
Indicator
PRAX
EXP
Relative Strength Index (RSI) 58.43 43.88
Support Level $291.44 $202.15
Resistance Level N/A $223.21
Average True Range (ATR) 19.51 5.83
MACD 2.70 -0.88
Stochastic Oscillator 76.31 17.16

Price Performance

Historical Comparison
PRAX
EXP

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About EXP Eagle Materials Inc

Eagle Materials Inc produces and sells construction products and building materials. Construction products include cement, slag, concrete, and aggregates and building materials include cement and gypsum wallboard, and are sold to the construction and building industries. The firm organizes itself into two sectors: Heavy Materials, which includes the Cement and Concrete and Aggregates segments, and Light Materials, which includes the Gypsum Wallboard and Recycled Paperboard segments.

Share on Social Networks: